When did Moderna report Q4 2024 earnings?

Moderna (MRNA) reported Q4 2024 earnings on February 14, 2025 before market open.

What were Moderna's Q4 2024 revenue and EPS?

Moderna reported revenue of $956.0M and diluted EPS of $-2.50 for Q4 2024.

Did Moderna beat estimates in Q4 2024?

Revenue beat the consensus estimate of $942.8M by $13.2M. EPS beat the consensus estimate of $-2.68 by $0.18.

Where can I find Moderna's Q4 2024 SEC filings?

You can read the 8-K earnings release (0001682852-25-000006) and the 10-K periodic report (0001682852-25-000022) directly on SEC EDGAR. The filing index links above go to sec.gov.

Moderna MRNA Q4 2024 Annual earnings

Reported February 14, 2025 · Before market open

Revenue$956.0MBeat by $13.2M Diluted EPS-$2.50Beat by $0.18

Revenue estimate$942.8M

EPS estimate-$2.68

Next report

Jul 31, 2026 (In 3 weeks)

Revenue estimate$101.7M

EPS estimate-$2.00

Financials

Q4 2024

Income statement

See full

Revenue$966.0M-65.6%

Gross profit$227.0M-87.9%

Operating income-$1.2B—

Net income-$1.1B—

EPS (diluted)-$2.91—

Balance sheet

See full

Cash & equivalents$1.9B-34.1%

Total debt$770.0M-38.1%

Total equity$10.9B-21.3%

Total assets$14.1B-23.2%

Cash flow

See full

CapEx$522.0M+137%

Free cash flow-—

Valuation & ratios

Valuation

as of 12/31/24

See full

Market cap$16B-57.8%

Enterprise value$14.84B-59.0%

P/S4.9×-0.6×

Profitability

See full

Gross margin54.8%+23.3pp

Operating margin-121.9%+3,532pp

Net margin-110%+123pp

FCF margin-134.7%—

Returns & leverage

See full

Return on equity-28.8%-1.1pp

Debt / equity0.1×0.0×

Current ratio3.7×+0.2×

Segments

By product

See full

Collaboration Arrangement, Including Arrangements With Affiliate$13.0M-35.0%

Grant revenue$10.0M—

Licensing and royalty revenue$5.0M—

Stand-ready manufacturing revenue-—

By geography

See full

Rest of world$213.3M-76.3%

Europe$149.5M-55.9%

Versus estimates

Revenue

Q1 2026$389.0MBeat by $152.6M Q4 2025$678.0MBeat by $42.8M Q3 2025$1.0BBeat by $95.1M Q2 2025$142.0MMiss by $751.3M Q1 2025$107.0MMiss by $9.7M

Q4 2024$956.0MBeat by $13.2M

Diluted EPS

Q1 2026-$1.18Beat by $1.84 Q4 2025-$2.11Beat by $0.43 Q3 2025-$0.51Beat by $1.36 Q2 2025-$2.13Beat by $0.86 Q1 2025-$2.52Beat by $0.40

Q4 2024-$2.50Beat by $0.18

Ask the moment Moderna reports.

Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.

Connect your AI

Claude

Questions, answered.

When did Moderna report Q4 2024 earnings?: Moderna (MRNA) reported Q4 2024 earnings on February 14, 2025 before market open.
What were Moderna's Q4 2024 revenue and EPS?: Moderna reported revenue of $956.0M and diluted EPS of $-2.50 for Q4 2024.
Did Moderna beat estimates in Q4 2024?: Revenue beat the consensus estimate of $942.8M by $13.2M. EPS beat the consensus estimate of $-2.68 by $0.18.
Where can I find Moderna's Q4 2024 SEC filings?: You can read the 8-K earnings release (0001682852-25-000006) and the 10-K periodic report (0001682852-25-000022) directly on SEC EDGAR. The filing index links above go to sec.gov.